Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-121363

President & CEO sold 2,170 shares at $13.58 ($29,469)

  • President & CEO acquired 5,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-05-16 Exercise or conversion : show line 1 in the form +5,625 $0.00 $1 19,103 D
2016-05-17 Sale : show line 2 in the form −2,170 $13.58 $29,469 16,933 D
Open-market sales · 2,170 sh · avg $13.58 · $29,469

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-05-16 Returned to the company : show line 3 in the form Restricted Stock Unit −5,625 $0.00 2016-05-16 5,625 56,250 D
Loading xslF345X03/doc4.xml…